“…Consequently, the loss of APAF-1 gene function leads to defects in the execution of apoptotic programmed cell death and may account for cellular resistance to chemo-, radio-, and immunotherapy. APAF-1 is located at chromosome loci 12q23 , and frequent AI in the 12q22-23 region has been reported in melanomas (Soengas et al, 2001;Fujimoto et al, 2004), male germ cell tumors (Murty et al, 1996), and pancreatic (Kimura et al, 1998;Yatsuoka et al, 2000), ovarian (Hatta et al, 1997) and gastric carcinomas (Schneider et al, 2003). In melanomas, AI is associated with a reduction of APAF-1 mRNA expression levels (Soengas et al, 2001;Fujimoto et al, 2004), and AI in the 12q22-23 region is related to poor prognosis of patients with American Joint Committee on Cancer (AJCC) stage III/IV melanoma .…”